01—History
Free Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $8.10B
YoY changeLargest recent move+41.2%in FY24Latest −22.1%
02—Ledger
Free Cash Flow, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $8.10B | −22.1% | 10-K | |
| FY2024 | $10.39B | +41.2% | 10-K | |
| FY2023 | $7.36B | −16.2% | 10-K | |
| FY2022 | $8.79B | +4.8% | 10-K | |
| FY2021 | $8.38B | −15.2% | 10-K | |
| FY2020 | $9.89B | +15.9% | 10-K | |
| FY2019 | $8.53B | −19.2% | 10-K | |
| FY2018 | $10.56B | +0.4% | 10-K | |
| FY2017 | $10.51B | +9.3% | 10-K | |
| FY2016 | $9.62B | +5.2% | 10-K | |
| FY2015 | $9.14B | +11.0% | 10-K | |
| FY2014 | $8.23B | +47.1% | 10-K | |
| FY2013 | $5.60B | +7.8% | 10-K | |
| FY2012 | $5.19B | +14.1% | 10-K | |
| FY2011 | $4.55B | −12.6% | 10-K | |
| FY2010 | $5.21B | −10.3% | 10-K | |
| FY2009 | $5.81B | +9.2% | 10-K | |
| FY2008 | $5.32B | +28.6% | 10-K | |
| FY2007 | $4.13B | — | 10-K |
03—Questions
What is AMGEN INC's current free cash flow?
AMGEN INC (AMGN) annual free cash flow for 2025 was $8.10B, a 22.07% decline from 2024. AMGEN INC free cash flow for the quarter ending March 31, 2026 was $1.48B.
What was AMGEN INC's free cash flow in 2024?
AMGEN INC annual free cash flow for 2024 was $10.39B, a 41.24% increase from 2023.
What was AMGEN INC's free cash flow in 2023?
AMGEN INC annual free cash flow for 2023 was $7.36B, a 16.23% decline from 2022.
What is AMGEN INC's 5-year free cash flow CAGR?
AMGEN INC free cash flow grew at a compound annual growth rate (CAGR) of 3.91% from FY2020 to FY2025, going from $9.89B to $8.10B over 5 years.
- Company
- AMGEN INC
- Ticker
- AMGN
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)